tiprankstipranks
Trending News
More News >
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market

BrightPath Biotherapeutics Co.Ltd. (4594) Revenue

Compare
0 Followers

BrightPath Biotherapeutics Co.Ltd. Revenue

BrightPath Biotherapeutics Co.Ltd. had a revenue of 23.00K in the quarter ending Dec 31, 2023, with -17.86%. This bring the company's revenue in the last twelve months to 118.00K, Increased -97.71%. In the fiscal year ending Mar 31, 2025, BrightPath Biotherapeutics Co.Ltd. had annual revenue of 1.13M with 1473.61% growth.
Revenue (ttm)
118.00K
Revenue Growth
1473.61%
P/S Ratio
7373.65
Revenue/Employee
¥26,976
Employees
42
Market Cap
¥8.35B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
1.13M1.06M+1,473.61%
Mar 31, 2024
72.00K-5.21M-98.64%
Mar 31, 2023
5.28M-10.13M-65.73%
Mar 31, 2022
15.41M12.90M+515.34%
Mar 31, 2021
2.50M-8.80M-77.84%
Mar 31, 2020
11.30M-144.51M-92.75%
Mar 31, 2019
155.81M-198.60M-56.04%
Mar 31, 2018
354.41M-175.20M-33.08%
Mar 31, 2017
529.61M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis